Providing Full Service Solutions for Injectable Drug Delivery

Printer-friendly version

Unilife provides an introduction to some significant trends in the pharma industry, such as the use of mobile electronics and smart phone apps, and the move of injectable medication delivery away from the clinical setting to wherever the user is, and describes some of the implications. We bring  in the concept of the delivery device as a valuable brand differentiator in a market of similar therapeutic molecules to drive preference amongst increasingly medication brand-aware patients. We further highlight Unilife’s portfolio of flexible, customisable device platforms, and the model of “Innovation within a Standard Footprint” which enables the development of innovative devices for pharma customers, without the need for them to retrofit established manufacturing and supply-chain processes.